Glaukos Corp. <GKOS.N>: Wells Fargo raises target price to $178 from $138
GKOS•Related News
Equipment maker Terex Q2 sales beat estimates, lifts FY outlook
TEX•
Buzz-Drug maker Regeneron gains after upbeat Q2 results
REGN•
Evogene to release Q2 2026 financial results
EVGN•
Biogen <BIIB.O>: Wedbush raises target price to $215 from $201
BIIB•
Allegro MicroSystems swings to GAAP profit of $15.9 million in FY27 Q1; net sales rise 27% to $259.2 million year-over-year
ALGM•